Somewhere around 200 million people worldwide live with age-related macular degeneration, and for those with the dry form of ...
PARIS, April 23, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery ...
Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other ...
A new laser-based treatment could help the eye repair itself before vision loss becomes permanent.
A group of blind patients can now read again after being fitted with a life-changing implant at the back of the eye. A surgeon who inserted the microchips in five patients at Moorfields Eye Hospital ...